Cooling is not about switching a system on and hoping for comfort. It is about control, planning, and execution that leaves no room for guesswork. Many homes deal with uneven temperatures because the ...

AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer's Disease Treatment of first patient in Cohort AD4 in ABATE trial triggers $12 ...

As the Army enhances Soldier lethality, Joint Program Executive Office for Armaments and Ammunition’s (JPEO A&A) Product ...

Dosed first subjects in Phase 1 trial of brain-penetrant small molecule NLRP3 inhibitor ACI-19764 with SAD/MAD results in healthy volunteers expected in H2 2026 Initiated final cohort, AD4, in ABATE ...

AC Immune First Quarter 2026 Financial and Corporate Updates Dosed first subjects in Phase 1 trial of brain-penetrant small molecule NLRP3 inhibitor ACI-19764 with SAD/MAD results in healthy volunteer ...

Andhra Pradesh IT Minister, Nara Lokesh laid the foundation stone for Carrier Global's manufacturing facility, expected to ...

Andhra Pradesh IT Minister Nara Lokesh lays the foundation stone for Carrier Global’s ₹1,000 crore AC manufacturing facility ...

Swiss biotech AC Immune discusses its PET tracer's potential in realising precision medicine approaches to neurodegenerative ...

East Coast flagship cGMP facility will increase Ac-225 production capacity twentyfold, supporting the next generation of ...

The study, published in Nature Medicine, shows that future risk of 18 obesity-related diseases can be predicted using 20 ...

As of the close of play on April 24, the broader consensus sentiments towards Praxis Precision Medicines Inc. (NASDAQ:PRAX) ...

The U.S. FDA has accepted Praxis Precision Medicines' New Drug Application for ulixacaltamide to treat essential tremor. The agency has also granted ulixacaltamide Breakthrough Therapy Designation.